<DOC>
	<DOCNO>NCT01302353</DOCNO>
	<brief_summary>In trial , primary goal investigate safety intravenous infusion emulsify isoflurane . In order protect volunteer , investigator adopt modify Fibonacci dose-escalation , start low dose derive 1/600 acute LD50 pre-clinic study . The trial terminate half volunteer develop severe adverse event dose group volunteer develop fatal adverse event group .</brief_summary>
	<brief_title>Phase I Trial Emulsified Isoflurane</brief_title>
	<detailed_description />
	<mesh_term>Isoflurane</mesh_term>
	<criteria>Age 18~45 year old ( 50:50 male : female ) healthy volunteer ; Body Mass Index ( BMI ) 19~24 ; health volunteer assess medical history physical examination systolic blood pressure 100~140mmHg ; heart rate 60~100bpm ; pulse oxygen saturation &gt; 97 % inspire air reach 100 % inspire 100 % oxygen 5 min ; normal result routine lab test , include complete blood count , chemical test , urine test stool test ; Nonsmoker history alcohol drug abuse ; Fully understand whole process trial sign inform consent . Any history allergy , especially isoflurane intralipid ; Any suspect history malignant hyperthermia volunteer his/her relative ; Recent use medication pronounce effect central nervous system organ ( within 3 month ) Recent participation clinical trial ( within 1 month ) Any history difficult airway suspect difficult airway ; Pregnancy ; Hyperlipidemia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Phase I trial</keyword>
	<keyword>Emulsified Isoflurane</keyword>
	<keyword>Health volunteer</keyword>
</DOC>